Impact of MOUD Policy Changes During the Pandemic

This study is looking at how changes in federal and state policies during the COVID-19 pandemic affected the use of medications for opioid use disorder (MOUD), specifically methadone and buprenorphine. It also looks at how these changes impacted medications for alcohol use disorder (MAUD). Researchers want to understand if these policy changes made it easier for people with opioid or alcohol use disorder to get and stay on these important treatments. They will also examine how these changes affected health outcomes like emergency room visits, hospitalizations, and overdoses. You may be able to join this study if you are 18 or older and have a documented substance use disorder (alcohol or opioid) within the Veteran's Health Administration.

Study design
This is an observational study, meaning researchers will look at existing health records rather than giving new treatments. It plans to include a large number of participants, about 185,810 individuals.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
The study will look at changes in MOUD/MAUD receipt, coverage, and retention over a period of 4 years before and after policy changes.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07232641

Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic

Recruiting
Not specifiedAges 18+Observational
Boston University
~185,810 participants
Updated 2026-07-02 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in MOUD/MAUD Receipt
Measured over 4 years pre/post policy change
+4 more outcomes measured
Substance Use Disorders
Alcohol Use Disorder
Opioid Use Disorder
1 sites across 1 states
Massachusetts1
  • Nicholas Livingston, PhD · PRINCIPAL_INVESTIGATOR · BUCA School of Medicine, Psychiatry and VA Medical Center

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Substance use disorder (alcohol and/or opioid) documented in the Veteran's Health Administration Corporate Data Warehouse (CDW)

Exclusion

None
  • Change in MOUD/MAUD Receipt4 years pre/post policy change

    Based on Current Procedural Terminology (CPT) codes abstracted from the Veterans Administration VA Corporate Data Warehouse (CDW)

  • Change in MOUD/MAUD Coverage4 years pre/post policy change

    Based on Current Procedural Terminology (CPT) codes abstracted from the Veterans Administration VA Corporate Data Warehouse (CDW)

  • Change in MOUD/MAUD Retention4 years pre/post policy change

    Based on Current Procedural Terminology (CPT) codes abstracted from the Veterans Administration VA Corporate Data Warehouse (CDW)

  • Change in Behavioral Therapy Receipt4 years pre/post policy change

    Based on Current Procedural Terminology (CPT) codes abstracted from the Veterans Administration VA Corporate Data Warehouse (CDW)

  • Change in Behavioral Therapy Count4 years pre/post policy change

    Based on Current Procedural Terminology (CPT) codes abstracted from the Veterans Administration VA Corporate Data Warehouse (CDW)